These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33190073)

  • 1. Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties.
    Yamaguchi-Sasaki T; Kawaguchi T; Okada A; Tokura S; Tanaka-Yamamoto N; Takeuchi T; Ogata Y; Takahashi R; Kurimoto-Tsuruta R; Tamaoki T; Sugaya Y; Abe-Kumasaka T; Arikawa K; Yoshida I; Sugiyama H; Kanuma K; Yoshinaga M
    Bioorg Med Chem; 2020 Dec; 28(24):115818. PubMed ID: 33190073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors.
    Yamaguchi-Sasaki T; Tamura Y; Ogata Y; Kawaguchi T; Kurosaka J; Sugaya Y; Iwakiri K; Busujima T; Takahashi R; Ueda-Yonemoto N; Tanigawa E; Abe-Kumasaka T; Sugiyama H; Kanuma K
    Chem Pharm Bull (Tokyo); 2020; 68(4):345-362. PubMed ID: 32238652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus entry inhibitors targeting the F protein.
    Sun Z; Pan Y; Jiang S; Lu L
    Viruses; 2013 Jan; 5(1):211-25. PubMed ID: 23325327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study.
    Mackman RL; Sangi M; Sperandio D; Parrish JP; Eisenberg E; Perron M; Hui H; Zhang L; Siegel D; Yang H; Saunders O; Boojamra C; Lee G; Samuel D; Babaoglu K; Carey A; Gilbert BE; Piedra PA; Strickley R; Iwata Q; Hayes J; Stray K; Kinkade A; Theodore D; Jordan R; Desai M; Cihlar T
    J Med Chem; 2015 Feb; 58(4):1630-43. PubMed ID: 25574686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
    Yoshida I; Arikawa K; Honma Y; Inatani S; Yoshinaga M; Sugiyama H
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms.
    Douglas JL; Panis ML; Ho E; Lin KY; Krawczyk SH; Grant DM; Cai R; Swaminathan S; Chen X; Cihlar T
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2460-6. PubMed ID: 15917547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.
    Zheng X; Gao L; Wang L; Liang C; Wang B; Liu Y; Feng S; Zhang B; Zhou M; Yu X; Xiang K; Chen L; Guo T; Shen HC; Zou G; Wu JZ; Yun H
    J Med Chem; 2019 Jul; 62(13):6003-6014. PubMed ID: 31194544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.
    Hwang JY; Windisch MP; Jo S; Kim K; Kong S; Kim HC; Kim S; Kim H; Lee ME; Kim Y; Choi J; Park DS; Park E; Kwon J; Nam J; Ahn S; Cechetto J; Kim J; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7297-301. PubMed ID: 23159569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins.
    Yamaguchi-Sasaki T; Tokura S; Ogata Y; Kawaguchi T; Sugaya Y; Takahashi R; Iwakiri K; Abe-Kumasaka T; Yoshida I; Arikawa K; Sugiyama H; Kanuma K
    ACS Med Chem Lett; 2020 Jun; 11(6):1145-1151. PubMed ID: 32550994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121).
    Bonfanti JF; Meyer C; Doublet F; Fortin J; Muller P; Queguiner L; Gevers T; Janssens P; Szel H; Willebrords R; Timmerman P; Wuyts K; van Remoortere P; Janssens F; Wigerinck P; Andries K
    J Med Chem; 2008 Feb; 51(4):875-96. PubMed ID: 18254606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial Virus.
    Pribut N; Kaiser TM; Wilson RJ; Jecs E; Dentmon ZW; Pelly SC; Sharma S; Bartsch PW; Burger PB; Hwang SS; Le T; Sourimant J; Yoon JJ; Plemper RK; Liotta DC
    ACS Infect Dis; 2020 May; 6(5):922-929. PubMed ID: 32275393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    Human S; Hotard AL; Rostad CA; Lee S; McCormick L; Larkin EK; Peret TCT; Jorba J; Lanzone J; Gebretsadik T; Williams JV; Bloodworth M; Stier M; Carroll K; Peebles RS; Anderson LJ; Hartert TV; Moore ML
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion.
    Cockerill GS; Angell RM; Bedernjak A; Chuckowree I; Fraser I; Gascon-Simorte J; Gilman MSA; Good JAD; Harland R; Johnson SM; Ludes-Meyers JH; Littler E; Lumley J; Lunn G; Mathews N; McLellan JS; Paradowski M; Peeples ME; Scott C; Tait D; Taylor G; Thom M; Thomas E; Villalonga Barber C; Ward SE; Watterson D; Williams G; Young P; Powell K
    J Med Chem; 2021 Apr; 64(7):3658-3676. PubMed ID: 33729773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein.
    Roymans D; De Bondt HL; Arnoult E; Geluykens P; Gevers T; Van Ginderen M; Verheyen N; Kim H; Willebrords R; Bonfanti JF; Bruinzeel W; Cummings MD; van Vlijmen H; Andries K
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):308-13. PubMed ID: 19966279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.
    Gaillard V; Galloux M; Garcin D; Eléouët JF; Le Goffic R; Larcher T; Rameix-Welti MA; Boukadiri A; Héritier J; Segura JM; Baechler E; Arrell M; Mottet-Osman G; Nyanguile O
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.